Search
Check Out Our Sponsors
Latest topics
Intravenous human immunoglobulin for treatment of folliculitis decalvans
Page 1 of 1
Intravenous human immunoglobulin for treatment of folliculitis decalvans
J Dermatolog Treat. 2015 Mar 23:1-2. [Epub ahead of print]
Intravenous human immunoglobulin for treatment of folliculitis decalvans.
Ismail N1, Ralph N, Murphy G.
We report a case of folliculitis decalvans (FD) successfully treated with intravenous human immunoglobulin (HIG). Many conventional treatments with topical agents and oral antibiotics had failed to achieve disease remission, treatment with HIG at a dose of 2 g/kg for the first month, reduced to 1 g/kg for second to fourth months was therefore started, which resulted in rapid improvement and ultimately complete resolution of FD. Clinical improvement was noted after the first infusion of HIG and remission of inflammation was achieved after the fourth infusion. Disease remission was sustained for six months following the last HIG infusion. The exact mechanism of action of HIG is poorly understood. However, it is thought to act as an immunomodulatory agent by altering different components of immune functions. To our knowledge, this is the first case reported in the literature of FD successfully treated with intravenous HIG.
Intravenous human immunoglobulin for treatment of folliculitis decalvans.
Ismail N1, Ralph N, Murphy G.
We report a case of folliculitis decalvans (FD) successfully treated with intravenous human immunoglobulin (HIG). Many conventional treatments with topical agents and oral antibiotics had failed to achieve disease remission, treatment with HIG at a dose of 2 g/kg for the first month, reduced to 1 g/kg for second to fourth months was therefore started, which resulted in rapid improvement and ultimately complete resolution of FD. Clinical improvement was noted after the first infusion of HIG and remission of inflammation was achieved after the fourth infusion. Disease remission was sustained for six months following the last HIG infusion. The exact mechanism of action of HIG is poorly understood. However, it is thought to act as an immunomodulatory agent by altering different components of immune functions. To our knowledge, this is the first case reported in the literature of FD successfully treated with intravenous HIG.
_________________
My regimen
http://www.immortalhair.org/mpb-regimen
Now available for consultation (hair and/or health)
http://www.immortalhair.org/health-consultation
Similar topics
» Folliculitis decalvans: a multicentre review of 82 patients
» Hospital-based Intravenous Vitamin C Treatment for Coronavirus and Related Illnesses
» Orthomolecular Treatment for Adverse Effects of Human Papilloma Virus (HPV) Vaccine
» Human placental extract exerts hair growth-promoting effects through the GSK-3β signaling pathway in human dermal papilla cells.
» Folliculitis
» Hospital-based Intravenous Vitamin C Treatment for Coronavirus and Related Illnesses
» Orthomolecular Treatment for Adverse Effects of Human Papilloma Virus (HPV) Vaccine
» Human placental extract exerts hair growth-promoting effects through the GSK-3β signaling pathway in human dermal papilla cells.
» Folliculitis
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|
Today at 8:05 am by CausticSymmetry
» zombie cells
Sat May 11, 2024 6:54 am by CausticSymmetry
» Sandalore - could it be a game changer?
Wed May 08, 2024 9:45 pm by MikeGore
» *The first scientific evidence in 2021 that viruses do not exist*
Tue May 07, 2024 4:18 am by CausticSymmetry
» China is at it again
Tue May 07, 2024 4:07 am by CausticSymmetry
» Ways to increase adult stem cells
Mon May 06, 2024 5:40 pm by el_llama
» pentadecanoic acid
Sun May 05, 2024 10:56 am by CausticSymmetry
» Exosome Theory and Herpes
Fri May 03, 2024 3:25 am by CausticSymmetry
» Road to recovery - my own log of everything I'm currently trying for HL
Tue Apr 30, 2024 1:55 pm by JtheDreamer